ASO Author Reflections: Controversies at the Tumor Board—The Gray Areas in the Multimodality Treatment of Resectable Non-small Cell Lung Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-025-17459-7
Published Online: 2025-05-19
Published Print: 2025-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Naeem, Wara
Khan, Arsalan A.
Seder, Christopher W.
Text and Data Mining valid from 2025-05-19
Version of Record valid from 2025-05-19
Article History
Received: 23 April 2025
Accepted: 24 April 2025
First Online: 19 May 2025
Disclosures
: The authors declare that they have no conflict of interest.